{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-038391","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2026-08-14T20:15:56+00:00","discovered_at":"2026-08-14T20:24:00.845452+00:00","generated_at":"2026-08-14T20:24:23.600500+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BioRestorative suspends ExoCR and BioX product shipments pending regulatory review","bullets":["Suspended all orders and shipments of ExoCR and BioX biocosmeceutical product lines effective August 7, 2026.","Suspension pending business review and regulatory assessment of documentation, sourcing, and regulatory status.","Company has not decided to discontinue these product lines.","Review could result in costs, need for additional capital, and uncertainty about resuming sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-038391","json":"https://secwatch.observer/filing/0001493152-26-038391.json","markdown":"https://secwatch.observer/filing/0001493152-26-038391.md","text":"https://secwatch.observer/filing/0001493152-26-038391.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000149315226038391/0001493152-26-038391-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000149315226038391/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-14T20:24:23.600500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}